Abstract
Many new therapies for dementia target a specific pathologic process and must be applied early. Selection of specific therapy is based on the clinical etiologic diagnosis. We sought to determine the stability of the clinical etiologic diagnosis over time and to identify factors associated with instability. We identified 4141 patients with dementia or mild cognitive impairment who made at least 2 visits approximately a year apart to a dementia research center, receiving a clinical etiologic diagnosis on each visit. We assessed concordance of etiologic diagnoses across visits, κ-statistics, and transition probabilities among diagnoses. The primary clinical etiologic diagnosis remained stable for 91% of patients but with a net shift toward dementia with Lewy bodies and Alzheimer's disease. Lower diagnostic stability was significantly associated with older age, nonwhite race, milder disease at presentation, more underlying conditions contributing to cognitive decline, lack of a consistent spouse/partner informant, and being evaluated by different clinicians on different visits. Multistate Markov modeling generally confirmed these associations. Clinical etiologic diagnoses were generally stable. However, several readily ascertained ...Continue Reading
References
Aug 24, 2000·Epidemiology·J M RobinsB Brumback
Dec 13, 2000·Neurology·D B CarrJ C Morris
Aug 10, 2002·The Medical Clinics of North America·Walter A Kukull, James D Bowen
Oct 22, 2003·Epidemiology·Tosiya Sato, Yutaka Matsuyama
May 11, 2005·Neurology·S GilmanUNKNOWN AN1792(QS-21)-201 Study Team
Mar 15, 2006·European Neurology·H Chabriat, M G Bousser
Nov 30, 2006·Alzheimer Disease and Associated Disorders·John C MorrisWalter A Kukull
Apr 28, 2007·Expert Opinion on Investigational Drugs·Jacqueline Birks, Leon Flicker
Nov 28, 2007·Annual Review of Pathology·Daniel M SkovronskyJohn Q Trojanowski
Jan 29, 2008·Current Alzheimer Research·Manfred WindischRobert Wronski
Jan 6, 2009·BMC Neuroscience·Jianhua ZhouTie Zou
Jun 3, 2009·Alzheimer Disease and Associated Disorders·Theodore K MalmstromJohn C Morris
Oct 29, 2009·JAMA : the Journal of the American Medical Association·Doris Lambracht-WashingtonRoger N Rosenberg
Dec 15, 2010·Archives of Neurology·Matthew J GabelEdward Y Zamrini
Dec 24, 2010·Neurology·P S AisenB Vellas
Jan 20, 2011·JAMA : the Journal of the American Medical Association·Monique M B Breteler
Apr 26, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackCreighton H Phelps
Citations
Oct 2, 2014·European Journal of Clinical Nutrition·M Tsolaki
Mar 17, 2016·Schizophrenia Bulletin·Paolo Fusar-PoliWilliam T Carpenter
Feb 11, 2015·Journal of the International Neuropsychological Society : JINS·Andrea M LoftusNatalie Gasson
Jun 25, 2016·Journal of the American Geriatrics Society·Daniela KollerJulie P W Bynum
Jun 16, 2017·International Psychogeriatrics·Fabiano Moulin de Moraes, Paulo Henrique Ferreira Bertolucci
Feb 26, 2016·Alzheimer Disease and Associated Disorders·Michael Malek-Ahmadi
May 12, 2017·Neurology·Liesbeth AertsHenry Brodaty
Mar 3, 2017·Journal of Neurology, Neurosurgery, and Psychiatry·Rachael A LawsonUNKNOWN ICICLE-PD study group
Jul 5, 2018·Behavioural Neurology·Pei-Hao ChenChih-Ho Chou
May 16, 2019·International Journal of Geriatric Psychiatry·Barry W RovnerBenjamin Leiby
Oct 12, 2018·Journal of the International Neuropsychological Society : JINS·Tess E K CersonskyStephanie Cosentino
Dec 7, 2017·American Journal of Alzheimer's Disease and Other Dementias·Fabiano Moulin de Moraes, Paulo Ferreira Bertolucci
Jun 5, 2018·Journal of Current Glaucoma Practice·Moon J LeePradeep Y Ramulu
Jul 27, 2021·Soins. Gérontologie·Claire SanlavilleLaurent Letrilliart